Metronomics: towards personalized chemotherapy?

N André, M Carré, E Pasquier - Nature reviews Clinical oncology, 2014 - nature.com
Since its inception in 2000, metronomic chemotherapy has undergone major advances as
an antiangiogenic therapy. The discovery of the pro-immune properties of chemotherapy …
被引用次数：321 相关文章
[PDF] academia.edu

[PDF][PDF] Metronomics: towards personalized chemotherapy?

N André, M Carré, E Pasquier - NATURE REVIEWS| CLINICAL …, 2014 - academia.edu
Since its inception in 2000, metronomic chemotherapy has undergone major advances as
an antiangiogenic therapy. The discovery of the pro‑immune properties of chemotherapy …

Metronomics: towards personalized chemotherapy?

N Andre, M Carre, E Pasquier - Nature Reviews Clinical Oncology, 2014 - go.gale.com
Since its inception in 2000, metronomic chemotherapy has undergone major advances as
an antiangiogenic therapy. The discovery of the pro-immune properties of chemotherapy …

Metronomics: towards personalized chemotherapy?

N André, M Carré, E Pasquier - Nature reviews. Clinical Oncology, 2014 - europepmc.org
Since its inception in 2000, metronomic chemotherapy has undergone major advances as
an antiangiogenic therapy. The discovery of the pro-immune properties of chemotherapy …

[引用][C] Metronomics: towards personalized chemotherapy?

N André, M Carré, E Pasquier - Nature Reviews Clinical Oncology, 2014 - cir.nii.ac.jp

Metronomics: towards personalized chemotherapy?

N André, M Carré, E Pasquier - Nature reviews. Clinical …, 2014 - pubmed.ncbi.nlm.nih.gov
Since its inception in 2000, metronomic chemotherapy has undergone major advances as
an antiangiogenic therapy. The discovery of the pro-immune properties of chemotherapy …

[引用][C] Metronomics: towards personalized chemotherapy?

N André, M Carré, E Pasquier - Nature Reviews. Clinical …, 2014 - Nature Publishing Group